MeSH term
Frequency | Condition_Probility | Humans | 250 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Mutagenesis, Site-Directed | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 183 | 0.0 |
Structure-Activity Relationship | 4 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Adolescent | 20 | 0.0 |
Aged | 36 | 0.0 |
*Liver Transplantation | 8 | 5.0 |
Male | 102 | 0.0 |
Middle Aged | 69 | 0.0 |
*Mutation | 15 | 0.0 |
Adult | 67 | 0.0 |
DNA Mutational Analysis | 7 | 0.0 |
Japan | 8 | 0.0 |
Point Mutation | 8 | 0.0 |
Prealbumin/*genetics | 54 | 98.0 |
Recurrence | 2 | 0.0 |
Amino Acid Sequence/genetics | 2 | 0.0 |
Amyloid/metabolism | 4 | 9.0 |
Base Sequence/genetics | 3 | 0.0 |
DNA/genetics | 5 | 0.0 |
Disease Progression | 3 | 0.0 |
Female | 100 | 0.0 |
Haplotypes | 2 | 0.0 |
Pedigree | 33 | 0.0 |
Polymorphism, Restriction Fragment Length | 11 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 18 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 83 | 0.0 |
Sural Nerve/metabolism/pathology | 2 | 22.0 |
Time Factors | 8 | 0.0 |
*Variation (Genetics) | 10 | 0.0 |
Base Sequence | 34 | 0.0 |
Binding Sites | 17 | 0.0 |
Binding, Competitive | 8 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
DNA Primers | 2 | 0.0 |
Escherichia coli/genetics | 2 | 0.0 |
Kinetics | 12 | 0.0 |
Models, Molecular | 24 | 0.0 |
Molecular Sequence Data | 47 | 0.0 |
Prealbumin/*metabolism | 14 | 66.0 |
Pregnancy | 6 | 0.0 |
Protein Structure, Secondary | 9 | 0.0 |
Tretinoin/metabolism | 2 | 5.0 |
Blood Proteins/analysis | 2 | 1.0 |
Prealbumin/*analysis | 12 | 63.0 |
Retinol-Binding Proteins/*analysis | 2 | 40.0 |
*Liver Transplantation/mortality | 2 | 66.0 |
Prognosis | 4 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
Prealbumin/chemistry/genetics/*metabolism | 5 | 100.0 |
Protein Structure, Quaternary | 3 | 1.0 |
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 7 | 2.0 |
Variation (Genetics) | 16 | 0.0 |
Animals | 54 | 0.0 |
Cell Line | 2 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Mice | 30 | 0.0 |
Nuclear Proteins/*biosynthesis/metabolism | 2 | 50.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Cells, Cultured | 5 | 0.0 |
DNA/analysis | 6 | 0.0 |
Polymerase Chain Reaction | 24 | 0.0 |
Polymorphism, Single-Stranded Conformational | 4 | 0.0 |
Portugal | 8 | 12.0 |
Amino Acid Sequence | 33 | 0.0 |
Amyloid/*chemistry/genetics | 2 | 66.0 |
Amyloid Neuropathies, Familial/*genetics | 2 | 100.0 |
*Point Mutation | 11 | 0.0 |
Prealbumin/chemistry/*genetics/metabolism | 4 | 100.0 |
Retinol-Binding Proteins/metabolism | 4 | 33.0 |
Surface Properties | 2 | 1.0 |
Brain/pathology | 4 | 1.0 |
Biopsy | 6 | 0.0 |
Macromolecular Substances | 9 | 0.0 |
Oxidative Stress | 3 | 0.0 |
Prealbumin/genetics | 7 | 43.0 |
Protein Binding | 19 | 0.0 |
RNA, Messenger/analysis/biosynthesis | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Amino Acid Substitution | 7 | 0.0 |
Amyloid/*metabolism | 8 | 15.0 |
Crystallography, X-Ray/methods | 2 | 8.0 |
Dimerization | 10 | 0.0 |
Fluorescent Dyes | 3 | 0.0 |
Hydrogen-Ion Concentration | 13 | 1.0 |
Protein Denaturation | 7 | 2.0 |
Spectrometry, Fluorescence | 2 | 0.0 |
Urea | 2 | 9.0 |
Liver Transplantation/*physiology | 2 | 10.0 |
Antibody Specificity | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 5 | 0.0 |
Heterozygote | 13 | 0.0 |
Mutation/*genetics | 6 | 0.0 |
Phenotype | 4 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Spectrum Analysis, Mass | 9 | 1.0 |
Circular Dichroism | 4 | 0.0 |
Microscopy, Electron | 9 | 0.0 |
Thermodynamics | 2 | 0.0 |
Drug Design | 2 | 0.0 |
*Protein Conformation | 4 | 1.0 |
Chromatography, High Pressure Liquid | 10 | 0.0 |
Precipitin Tests | 6 | 0.0 |
Amyloidosis/genetics/*pathology | 2 | 40.0 |
*Disease Models, Animal | 5 | 1.0 |
Gene Expression | 5 | 0.0 |
Mice, Inbred C57BL | 9 | 0.0 |
Microscopy, Immunoelectron | 2 | 0.0 |
Prealbumin/analysis/*genetics | 4 | 100.0 |
Transgenes | 2 | 0.0 |
Aged, 80 and over | 12 | 0.0 |
Child | 13 | 0.0 |
Iodine Radioisotopes/diagnostic use | 3 | 0.0 |
Radioimmunoassay | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 15 | 0.0 |
Hamsters | 2 | 0.0 |
Ligands | 5 | 0.0 |
Liver/metabolism | 3 | 0.0 |
Mutation | 34 | 0.0 |
Rats | 14 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Temperature | 4 | 0.0 |
Tissue Distribution | 7 | 0.0 |
Age of Onset | 6 | 0.0 |
Amyloid Neuropathies/genetics | 3 | 100.0 |
Crystallography, X-Ray | 10 | 1.0 |
Hydrogen Bonding | 6 | 3.0 |
Prealbumin/*chemistry/genetics/*metabolism | 4 | 100.0 |
Protein Conformation | 21 | 0.0 |
Protein Subunits | 3 | 0.0 |
Thyroxine/chemistry/metabolism | 2 | 100.0 |
Gene Therapy/*methods | 2 | 0.0 |
Myocardium/pathology | 2 | 2.0 |
Prealbumin/*chemistry/*genetics | 3 | 100.0 |
Prealbumin/*chemistry/*metabolism | 2 | 100.0 |
Comparative Study | 24 | 0.0 |
Prealbumin/*chemistry/genetics/metabolism | 3 | 100.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Solubility | 2 | 0.0 |
Iodine Radioisotopes | 7 | 1.0 |
Prealbumin/chemistry/*metabolism | 4 | 100.0 |
Radioligand Assay | 2 | 0.0 |
Immunohistochemistry | 17 | 0.0 |
Transfection | 4 | 0.0 |
Biological Markers/blood | 2 | 0.0 |
English Abstract | 8 | 0.0 |
Rabbits | 4 | 0.0 |
*Spectrum Analysis, Mass | 2 | 25.0 |
Amyloidosis/blood/*genetics | 6 | 100.0 |
Cholesterol/blood | 2 | 0.0 |
In Vitro | 5 | 0.0 |
Kidney/*metabolism | 2 | 1.0 |
Amyloid Neuropathies/*genetics | 6 | 100.0 |
Isoleucine/*genetics | 2 | 25.0 |
Amyloid Neuropathies/blood/*diagnosis/genetics | 2 | 100.0 |
Prealbumin/*analysis/genetics | 3 | 100.0 |
*Amino Acid Substitution | 2 | 2.0 |
Amyloid/chemistry | 3 | 100.0 |
Congo Red | 2 | 13.0 |
Dyes | 2 | 1.0 |
Exons/genetics | 7 | 0.0 |
Glycine/analysis | 2 | 50.0 |
Molecular Weight | 8 | 0.0 |
*Polymorphism, Single-Stranded Conformational | 2 | 1.0 |
Amyloid Neuropathies/genetics/*metabolism | 2 | 100.0 |
Blotting, Western | 7 | 0.0 |
Prealbumin/genetics/*metabolism | 10 | 100.0 |
Alanine | 4 | 4.0 |
Mutation/genetics | 8 | 0.0 |
Tyrosine | 4 | 3.0 |
Prealbumin/chemistry/*genetics | 6 | 100.0 |
Sequence Analysis | 5 | 1.0 |
Protein Binding/genetics | 2 | 0.0 |
Titrimetry | 3 | 10.0 |
Amyloidosis/*etiology | 2 | 25.0 |
Leucine/*genetics | 3 | 12.0 |
Ultracentrifugation | 2 | 1.0 |
Methionine/chemistry/genetics | 3 | 100.0 |
Prealbumin/*chemistry/genetics | 3 | 100.0 |
Valine/chemistry/genetics | 2 | 66.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Restriction Mapping | 4 | 0.0 |
Sequence Analysis, DNA | 5 | 0.0 |
Spectrum Analysis, Mass/*methods | 3 | 7.0 |
Amyloid Neuropathies/*blood/*genetics | 2 | 100.0 |
Immunochemistry | 3 | 1.0 |
Prealbumin/*chemistry/*genetics/metabolism | 2 | 100.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Antibodies, Monoclonal/immunology | 3 | 0.0 |
Epitope Mapping | 3 | 1.0 |
Osmolar Concentration | 2 | 0.0 |
Reference Values | 7 | 0.0 |
Thyroxine-Binding Proteins/*metabolism | 2 | 33.0 |
Protein Folding | 6 | 1.0 |
Magnetic Resonance Imaging | 3 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Crystallization | 3 | 1.0 |
Prealbumin/*chemistry/metabolism | 3 | 100.0 |
*Renal Dialysis | 2 | 0.0 |
Amyloidosis/*genetics | 15 | 53.0 |
Chromatography, High Pressure Liquid/methods | 2 | 1.0 |
Methionine | 5 | 13.0 |
Valine | 3 | 5.0 |
Amyloid/analysis | 4 | 23.0 |
*Liver Transplantation/adverse effects | 2 | 33.0 |
Prealbumin/analysis | 4 | 16.0 |
Amyloid/*chemistry | 3 | 37.0 |
Models, Structural | 2 | 1.0 |
Prealbumin/*chemistry | 3 | 75.0 |
X-Ray Diffraction | 2 | 2.0 |
Amyloid Neuropathies/*genetics/*pathology | 3 | 75.0 |
Neural Conduction | 3 | 3.0 |
Neurophysiology | 2 | 66.0 |
Sural Nerve/pathology | 3 | 7.0 |
Child, Preschool | 10 | 0.0 |
Disease Models, Animal | 5 | 0.0 |
Retinol-Binding Proteins/*metabolism | 3 | 33.0 |
Family | 2 | 0.0 |
Computer Simulation | 3 | 0.0 |
Recombinant Proteins/chemistry | 2 | 0.0 |
Blood Urea Nitrogen | 2 | 3.0 |
Prospective Studies | 2 | 0.0 |
Serum Albumin/analysis | 3 | 1.0 |
Atrophy | 2 | 1.0 |
Biological Markers | 2 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Follow-Up Studies | 2 | 0.0 |
Serum Amyloid P-Component/*metabolism | 2 | 11.0 |
Treatment Outcome | 2 | 0.0 |
Immunosorbent Techniques | 2 | 0.0 |
Spectrum Analysis, Mass/methods | 2 | 5.0 |
Infant, Newborn | 3 | 0.0 |
Thyroid Hormones/*metabolism | 4 | 12.0 |
Brain/*metabolism | 3 | 0.0 |
Chromatography, Affinity | 5 | 0.0 |
Isoelectric Focusing | 3 | 0.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 2 | 0.0 |
Thyroxine/analysis/*metabolism | 2 | 100.0 |
Amyloid/*biosynthesis | 4 | 57.0 |
Age Factors | 6 | 0.0 |
Choroid Plexus/metabolism | 2 | 28.0 |
Mice, Transgenic | 14 | 0.0 |
DNA Probes | 2 | 0.0 |
Prealbumin/*biosynthesis | 4 | 66.0 |
RNA Probes | 3 | 2.0 |
Homozygote | 5 | 0.0 |
Thyroxine/blood | 2 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Peripheral Nerves/pathology | 3 | 14.0 |
Viscera/pathology | 2 | 33.0 |
Thyroxine/metabolism | 4 | 16.0 |
Amyloid/*analysis | 2 | 5.0 |
Liver Transplantation/physiology | 2 | 66.0 |
Prealbumin/*chemistry/drug effects | 2 | 100.0 |
*Protein Structure, Secondary | 3 | 2.0 |
Liver/embryology/*metabolism | 2 | 18.0 |
*Transcription, Genetic | 2 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
Thyrotropin/blood | 3 | 0.0 |
Triiodothyronine/blood | 2 | 0.0 |
Valine/genetics | 2 | 2.0 |
Chromatography, Affinity/methods | 2 | 2.0 |
Chromatography, Ion Exchange | 3 | 0.0 |
Prealbumin/*isolation & purification | 2 | 100.0 |
Prealbumin/*genetics/*metabolism | 2 | 50.0 |
Recombinant Proteins | 3 | 0.0 |
Thyroxine/blood/*metabolism | 2 | 50.0 |
Thyrotropin/*blood | 2 | 1.0 |
Heterozygote Detection | 2 | 0.0 |
Prealbumin/*genetics/metabolism | 6 | 85.0 |
Valine/*genetics | 2 | 9.0 |
DNA, Single-Stranded/genetics | 3 | 8.0 |
Genetic Screening | 2 | 0.0 |
Serum Albumin/metabolism | 2 | 1.0 |
Thyroxine/*metabolism | 4 | 50.0 |
Peripheral Nervous System Diseases/*genetics | 9 | 36.0 |
Carcinoma, Hepatocellular | 2 | 0.0 |
Liver Neoplasms | 2 | 0.0 |
Mice, Inbred Strains | 2 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Blotting, Southern | 3 | 0.0 |
Oligonucleotides/genetics | 2 | 5.0 |
Chromatography, Gel | 5 | 0.0 |
Brain Chemistry | 2 | 0.0 |
Prealbumin/biosynthesis/genetics | 2 | 100.0 |
Sweden | 4 | 1.0 |
Cysteine | 4 | 3.0 |
Prealbumin/genetics/metabolism | 3 | 60.0 |
Amyloidosis/metabolism | 2 | 20.0 |
In Situ Hybridization | 3 | 0.0 |
Prealbumin/metabolism | 3 | 15.0 |
Vitamin A/*metabolism | 2 | 9.0 |
Cattle | 2 | 0.0 |
Organ Specificity | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Genes, Structural | 2 | 0.0 |
Infant | 5 | 0.0 |
Amyloid/chemistry/ultrastructure | 2 | 100.0 |
Escherichia coli/metabolism | 2 | 0.0 |
Prealbumin/*chemistry/isolation & purification/ultrastructure | 2 | 100.0 |
Amyloidosis/diagnosis/*genetics | 2 | 50.0 |
Denmark | 3 | 1.0 |
Leucine/genetics | 2 | 3.0 |
Methionine/*genetics | 3 | 20.0 |
Oligodeoxyribonucleotides/genetics | 2 | 2.0 |
Retrospective Studies | 2 | 0.0 |
Asian Continental Ancestry Group | 2 | 0.0 |
Hereditary Motor and Sensory Neuropathies/*genetics | 3 | 6.0 |
Peptide Mapping | 6 | 1.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Amyloidosis/genetics | 3 | 50.0 |
Genotype | 4 | 0.0 |
Genes, Dominant/*genetics | 2 | 2.0 |
*Radioimmunoassay | 2 | 5.0 |
DNA/chemistry | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
*Genes | 2 | 0.0 |
*Homozygote | 2 | 1.0 |
Nucleic Acid Hybridization | 5 | 0.0 |
Amyloid/*chemistry/ultrastructure | 2 | 50.0 |
Nucleic Acid Conformation | 2 | 0.0 |
Proline/genetics | 3 | 5.0 |
Exons | 2 | 0.0 |
Nervous System Diseases/*genetics | 2 | 6.0 |
Peptide Fragments/analysis | 2 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Immunoenzyme Techniques | 4 | 0.0 |
Cardiomyopathies/*genetics | 2 | 16.0 |
Rats, Inbred Strains | 4 | 0.0 |
Alleles | 2 | 0.0 |
Incidence | 2 | 0.0 |
DNA Probes/genetics | 2 | 1.0 |
Tumor Markers, Biological/*analysis | 2 | 0.0 |
Oligonucleotide Probes | 4 | 0.0 |
DNA | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
Hereditary Sensory and Autonomic Neuropathies/*genetics | 2 | 14.0 |
Arginine/*genetics | 2 | 3.0 |
Germany | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Gene Therapy | 2 | 0.0 |
Spectrometry, Mass, Electrospray Ionization | 2 | 2.0 |
Plasmids | 3 | 0.0 |
Promoter Regions (Genetics) | 4 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Amyloidosis/genetics/*metabolism | 2 | 50.0 |
Prealbumin/*analysis/metabolism | 2 | 66.0 |
Microscopy, Atomic Force | 2 | 9.0 |
Prealbumin/*genetics/isolation & purification | 2 | 66.0 |
Liver/*metabolism | 3 | 0.0 |
Enhancer Elements (Genetics) | 2 | 0.0 |
Trypsin | 4 | 2.0 |
Disulfides | 2 | 2.0 |
Amino Acids/analysis | 3 | 1.0 |
Cyanogen Bromide | 3 | 5.0 |
Chemistry, Physical | 2 | 1.0 |
Mice, Knockout | 3 | 0.0 |
Amyloid Neuropathies, Familial/diagnosis/*genetics | 2 | 100.0 |
Rats, Wistar | 2 | 0.0 |